Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asacol in Pediatric Ulcerative Colitis
NCT00713310Phase 3Completed
- Sponsor
- Warner Chilcott
- Start
- Dec 2008
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of Salcrozine in ulcerative colitis (UC) (2 arms), sponsored by Warner Chilcott. Primary endpoint: Treatment Success based on Pediatric Ulcerative Colitis Activity Index at 6 weeks. Started Dec 2008; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00713310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00713310.